A new study finds Ephemeral’s tattoo ink can be safely used in radiation-therapy alignment for cancer treatment. Read about why this could be revolutionary for some patients.
Researchers in the Hermelin Brain Tumor Center at Henry Ford Health are leading a Phase I clinical trial studying the maximum tolerated dose of an oncolytic adenovirus, a mutated virus engineered to selectively replicate in and destroy cancer tissue, in combination with fractionated stereotactic radiosurgery among patients who are undergoing resection of a recurrent high-grade astrocytoma brain tumor.
However, for a range of reasons, from religious, cultural or personal preference, some patients don't want a permanent mark on their body. There were few choices, until now.
For most people, the decision to get a tattoo was made carefully and willingly, but many patients battling cancer were distressed to learn their treatment requires them to get several small tattoos.